In light of the European Commission’s recent initiatives to bolster private antitrust enforcement, this paper discusses the general economic framework for damages estimation, reviews common empirical methods used by economic experts and highlights some of the practical challenges for estimating private antitrust damages.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...